angiotensin ii has been researched along with Choroid Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukamizu, A; Ichihara, A; Ishida, S; Itoh, H; Nagai, N; Noda, K; Oike, Y; Ozawa, Y; Satofuka, S; Tsubota, K | 1 |
| Inoue, M; Ishida, S; Izumi-Nagai, K; Kubota, Y; Nagai, N; Noda, K; Oike, Y; Ozawa, Y; Suda, T; Tsubota, K; Urano, T | 1 |
2 other study(ies) available for angiotensin ii and Choroid Neovascularization
| Article | Year |
|---|---|
(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.
Topics: Angiotensin II; Animals; Chemokine CCL2; Choroidal Neovascularization; Endothelial Cells; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Intercellular Adhesion Molecule-1; Macrophages; Male; Mice; Mice, Inbred C57BL; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
Topics: Angiogenesis Inducing Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Cell Movement; Choroidal Neovascularization; Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Macrophages; Mice; Mice, Inbred C57BL; PPAR gamma; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Telmisartan; Tissue Distribution | 2006 |